Cardinal Health, Inc. (LON:0HTG)
London flag London · Delayed Price · Currency is GBP · Price in USD
152.12
-0.51 (-0.33%)
At close: Sep 12, 2025

Revenue by Product

Fiscal year is July - June.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2013 - 2020
Pharmaceutical and Specialty Solutions
204.64B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical and Specialty Solutions Growth
-2.56%
Log In
Log In
Log In
Log In
Upgrade
Global Medical Products and Distribution
12.64B
Log In
Log In
Log In
Log In
Upgrade
Global Medical Products and Distribution Growth
2.06%
Log In
Log In
Log In
Log In
Upgrade
Other Segment
5.38B
Log In
Log In
Log In
Log In
Upgrade
Other Segment Growth
19.28%
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Distribution and Specialty Solutions
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Distribution and Specialty Solutions Growth
-
Log In
Log In
Log In
Log In
Upgrade
Nuclear and Precision Health Solutions
-
Log In
Log In
Log In
Log In
Upgrade
Nuclear and Precision Health Solutions Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Distribution and Products
-
Log In
Log In
Log In
Log In
Upgrade
Medical Distribution and Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
Cardinal Health at-Home Solutions
-
Log In
Log In
Log In
Log In
Upgrade
Cardinal Health at-Home Solutions Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is July - June.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2013 - 2020
Other
3.12B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
37.05%
Log In
Log In
Log In
Log In
Upgrade
Corporate Profit
-634.00M
Log In
Log In
Log In
Log In
Upgrade
Corporate Profit Growth
-50.74%
Log In
Log In
Log In
Log In
Upgrade
Other
3.12B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
37.05%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical and Specialty Solutions Segment Profit
2.26B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical and Specialty Solutions Segment Profit Growth
12.06%
Log In
Log In
Log In
Log In
Upgrade
Global Medical Products and Distribution Segment Profit
135.00M
Log In
Log In
Log In
Log In
Upgrade
Global Medical Products and Distribution Segment Profit Growth
46.74%
Log In
Log In
Log In
Log In
Upgrade
Other Segment Segment Profit
516.00M
Log In
Log In
Log In
Log In
Upgrade
Other Segment Segment Profit Growth
21.99%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Segment Profit
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Segment Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Segment Profit
-
Log In
Log In
Log In
Log In
Upgrade
Medical Segment Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is July - June.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2013 - 2020
United States
220.99B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-1.88%
Log In
Log In
Log In
Log In
Upgrade
International
1.67B
Log In
Log In
Log In
Log In
Upgrade
International Growth
-0.71%
Log In
Log In
Log In
Log In
Upgrade